+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 490 Pages
  • Global
From
Intravenous Immunoglobulin Market by Application and Type: Global Opportunity Analysis and Industry Forecast, 2027 - Product Thumbnail Image

Intravenous Immunoglobulin Market by Application and Type: Global Opportunity Analysis and Industry Forecast, 2027

  • Report
  • July 2023
  • 179 Pages
  • Global
From
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Anti-diabetic Drugs Market - Product Thumbnail Image

Global Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1127 Pages
  • Global
From
Global Diabetes Care Drugs Market Analysis & Forecast to 2023-2033: Market By Drugs; By Type; By Rote of Administration; By End-user; and By Region - Product Thumbnail Image

Global Diabetes Care Drugs Market Analysis & Forecast to 2023-2033: Market By Drugs; By Type; By Rote of Administration; By End-user; and By Region

  • Report
  • August 2023
  • 145 Pages
  • Global
From
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 - Product Thumbnail Image

Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029

  • Drug Pipelines
  • December 2022
  • 148 Pages
  • Global
From
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030 - Product Thumbnail Image

Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030

  • Report
  • March 2021
  • 330 Pages
  • Global
From
Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028 - Product Thumbnail Image

Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028

  • Report
  • June 2022
  • 1500 Pages
  • Global
From
Global Fibromyalgia Therapeutics Market by Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Forecast 2024-2030 - Product Thumbnail Image

Global Fibromyalgia Therapeutics Market by Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Forecast 2024-2030

  • Report
  • March 2024
  • 183 Pages
  • Global
From
Global Celiac Disease Drugs Market by Drug (First Line of Treatment, Second Line of Treatment), Type (Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, Vitamins & Dietary Supplements), Indication, End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Celiac Disease Drugs Market by Drug (First Line of Treatment, Second Line of Treatment), Type (Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, Vitamins & Dietary Supplements), Indication, End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 191 Pages
  • Global
From
Global Inflammatory Bowel Disease Treatment Market by Type (Crohn's Disease, Ulcerative Colitis), Drug Class (Aminosalicylates, Anti-Integrin, Corticosteroids), Route of Administration, Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Inflammatory Bowel Disease Treatment Market by Type (Crohn's Disease, Ulcerative Colitis), Drug Class (Aminosalicylates, Anti-Integrin, Corticosteroids), Route of Administration, Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 186 Pages
  • Global
From
Global Multiple Myeloma Drugs Market 2023-2027 - Product Thumbnail Image

Global Multiple Myeloma Drugs Market 2023-2027

  • Report
  • October 2022
  • 120 Pages
  • Global
From
Global Non-insulin Diabetes Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Non-insulin Diabetes Therapeutics Market 2023-2027

  • Report
  • May 2023
  • 172 Pages
  • Global
From
Diabetes Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Diabetes Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Global Hereditary Angioedema Therapeutics Market by Drug Class (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor, Kallikrein Inhibitor), Treatment Type (On-Demand, Prophylaxis), Route Of Administration - Forecast 2024-2030 - Product Thumbnail Image

Global Hereditary Angioedema Therapeutics Market by Drug Class (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor, Kallikrein Inhibitor), Treatment Type (On-Demand, Prophylaxis), Route Of Administration - Forecast 2024-2030

  • Report
  • March 2024
  • 190 Pages
  • Global
From
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 419 Pages
  • Global
From
Global Type 2 Diabetes Market 2023-2027 - Product Thumbnail Image

Global Type 2 Diabetes Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 432 Pages
  • Global
From
Global Angioedema Treatment Market by Drugs Type (C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist), Route of Administration (Injections, Oral), End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Angioedema Treatment Market by Drugs Type (C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist), Route of Administration (Injections, Oral), End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 183 Pages
  • Global
From
Loading Indicator